The cellular biology of the Reed-Sternberg cell

Blood

Volumn 84, Issue 4, 1994, Pages 1005-1019

  Haluska, Frank G ^a   Brufsky, Adam M ^a   Canellos, George P ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 9; LYMPHOCYTE SURFACE MARKER;

CANCER GENETICS; CELL PROLIFERATION; CYTOGENETICS; EPSTEIN BARR VIRUS; GENOTYPE; HODGKIN DISEASE; HUMAN; IMMUNOGENETICS; IMMUNOPHENOTYPING; LYMPHOMA CELL LINE; ONCOGENE; PRIORITY JOURNAL; REED STERNBERG CELL; REVIEW;

EID: 0027935346     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v84.4.1005.bloodjournal8441005     Document Type: Review

References (249)

1. Taylor C: A history of the Reed-Sternberg cell. Biomedicine 28:196, 1978
2. Aisenberg A: A historical overview of malignant lymphoma, in Wiernik P, Canellos G, Kyle R, Schiffer C (eds): Neoplastic Diseases of the Blood. New York, NY, Churchill Livingstone, 1991, chapter 36, p 597
3. Haluska F, Tsujimoto Y, Croce C: The molecular genetics of non-Hodgkin's lymphomas, in Magrath I (ed): The Non-Hodgkin's Lymphomas. London, UK, Edward Arnold, 1990, chapter 6, p 96
4. Kaplan H, Gartner S: "Sternberg-Reed" giant cells of Hodgkin's disease: Cultivation in vitro, heterotransplantation, and characterization as neoplastic macrophages. Int J Cancer 19:511, 1977
5. Kadin M, Stites D, Levy R, Warnke R: Exogenous immunoglobulin and the macrophage origin of the Reed-Sternberg cells in Hodgkin's disease. N Engl J Med 299:1208, 1978
6. Kadin M: Possible origin of the Reed Sternberg cell from an interdigitating reticulum cell. Cancer Treat Rep 60:601, 1982
7. Curran R, Jones E: Hodgkin's disease: An immunohistochemical and histological study. J Pathol 125:39, 1978
8. Stein H, Uchanska-Zeigler B, Gerdes J, Ziegler A, Wernet P: Hodgkin and Sternberg-Reed cells contain antigens specific to late granulopoesis. Int J Cancer 29:283, 1982
9. Sinkovics J, Schullenberger C: Hodgkin's disease. Lancet 2:960, 1975
10. Warner T: Origin of the Reed-Sternberg cell. Lancet 2:5111, 1973
11. Bucsky P: Hodgkin's disease: The Reed-Sternberg cell. Blut 55:413, 1987
12. Drexler H, Jones D, Diehl V, Minowada J: Is the Hodgkin cell a T- or B-lymphocyte? Recent evidence from geno- and immunophenotypic analysis and in vitro cell lines. Hematol Oncol 7:95, 1989
13. Diehl V, von Kalle C, Fonatsch C, Tesch H, Juecker M, Schadt M: The cell of origin in Hodgkin's disease. Semin Oncol 17:660, 1990
14. Jaffe E: The elusive Reed-Sternberg cell. N Engl J Med 320:529, 1989
15. Schwab U, Stein H, Gerdes J, Lemke H, Kirchner H, Schaadt M, Diehl V: Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 299:185, 1982
16. Hsu S, Yang K, Jaffe E: Phenotypic expression of Hodgkin's and Reed-Sternberg cells in Hodgkin's disease. Am J Pathol 118:209, 1985
17. Kadin M, Muramoto L, Said J: Expression of T-cell antigens by Reed-Sternberg cells in Hodgkin's disease. Am J Pathol 130:345, 1988
18. Agnarsson B, Kadin M: The immunophenotype of Reed-Sternberg cells: A study of 50 cases of Hodgkin's disease using fixed frozen tissues. Cancer 63:2083, 1989
19. Falini B, Stein R, Pileri S, Canino S, Farabbi R, Martelli M, Grignani F, Fagoli M, Minelli O, Ciani C, Flenghi L: Expression of lymphoid-associated antigens on Hodgkin's and Reed-Sternberg cells in Hodgkin's disease. An immunocytochemical study on lymph node cytospins using monoclonal antibodies. Histopathology 11:1229, 1987
20. Dallenbach F, Stein H: Expression of T-cell receptor beta chain in Reed-Sternberg cells. Lancet 2:828, 1989
21. Casey T, Olson S, Cousar J, Collins R: Immunophenotypes of Reed-Sternberg cells: A study of 19 cases of Hodgkin's disease in plastic embedded sections. Blood 74:2624, 1989
22. Brinker M, Poppema S, Buys C, Timens W, Osinga J, Visser L: Clonal immunoglobulin gene rearrangements in tissues involved by Hodgkin's disease. Blood 70:186, 1987
23. Weiss L, Strickler J, Hu E, Warnke R, Sklar J: Immunoglobulin gene rearrangements in Hodgkin's disease. Hum Pathol 17:1009, 1986
24. Abdulaziz Z, Mason D, Stein H, Gatter K, Nash J: An immunohistological study of the cellular constituents of Hodgkin's disease using a monoclonal antibody panel. Histopathology 8:1, 1984
25. Angel C, Warford A, Campbell A, Pringle J, Lauder I: The immunohistology of Hodgkin's disease - Reed-Sternberg cells and their variants. J Pathol 153:21, 1987
26. Herbst H, Tippelmann G, Anagnostopoulos I, Gertes J, Schwarting R, Boehm T, Pileri S, Jones D, Stein H: Immunoglobulin and T-cell receptor gene rearrangements in Hodgkin's disease and Ki-1 positive anaplastic large cell lymphoma: Dissociation between genotype and phenotype. Leuk Res 13:103, 1989
27. Ruprai A, Pringle J, Angel C, Kind C, Lauder I: Localization of immunoglobulin light chain mRNA expression in Hodgkin's disease by in situ hybridization. J Pathol 164:37, 1991
28. Hell K, Pringle JH, Hansmann ML, Lorenzen J, Colloby P, Lauder I, Fischer R: Demonstration of light chain messenger RNA in Hodgkin's disease. J Pathol 171:137, 1993
29. Stuart A, Volssen S, Zola H: The reactivity of Reed-Sternberg cells with monoclonal antisera at thin section and ultrastructural levels. J Pathol 141:71, 1983
30. Schmid C, Pan L, Diss T, Issacson P: Expression of B-cell antigens by Hodgkin's and Reed-sternberg cells. Am J Pathol 139:701, 1991
31. Della Croce D, Imam A, Brynes R, Nathwani B, Taylor C: Anti BLA.36 monoclonal antibody shows reactivity with Hodgkin's cells and B lymphocytes in frozen and paraffin-embedded tissues. Hematol Oncol 9:103, 1991
32. Stein H, Hansmann M, Lennert K, Brandtzaeg P, Gatter K, Mason D: Reed-Sternberg and Hodgkin cells in lymphocyte-predominant Hodgkin's disease of nodular subtype contain J-chain. Am J Clin Pathol 96:292, 1986
33. Pinkus G, Said J: Hodgkin's disease, lymphocyte predominance type, nodular-further evidence for a B cell derivation. Am J Pathol 133:211, 1988
34. Timens W, Visser L, Poppema S: Nodular subtype predominance type of Hodgkin's disease is a germinal center lymphoma. Lab Invest 54:457, 1986
35. Carbone A, Manconi R, Poletti A, Sulfaro S, Menin A, Tirelli U, Betta P, Volpe R: Reed-Sternberg cells and their cell microenvironment in Hodgkin's disease with reference to macrophage-histiocytes and interdigitating reticulum cells. Cancer 60:2662, 1987
36. Beckstead J, Warnke R, Bainton D: Histochemistry of Hodgkin's disease. Cancer Treat Rep 66:609, 1982
37. Hsu S, Jaffe E: Leu M1 and peanut agglutinin stain the neoplastic cells of Hodgkin's disease. Am J Clin Pathol 82:29, 1984
38. Pinkus G, Thomas P, Said J: Leu M1-A marker for Reed-Sternberg cells in Hodgkin's disease. Am J Clin Pathol 119:242, 1985
39. Strauchen J, Breakstone B: Leu M1 antigen: Comparitive expression in Hodgkin's disease and T-cell lymphoma. Hematol Oncol 5:107, 1987
40. Wieczorek R, Burke J, Knowles D III: Leu-M1 antigen expression in T-cell neoplasia. Am J Pathol 121:374, 1985
41. Sheibani K, Battifora H, Burke J, Rappaport H: Leu-M1 antigen in human neoplasms: An immunohistologic study of 400 cases. Am J Surg Pathol 10:227, 1986
42. Ree H, Neiman R, Martin A, Dallenbach F, Stein H: Paraffin section markers for Reed-Sternberg cells. A comparative study of peanut agglutinin, Leu M1, LN-2 and Ber-H2. Cancer 63:2030, 1989
43. Pinkus G, Said J: Leu M1 immunoreactivity in nonhematopoetic neoplasms and myeolproliferative disorders. Am J Clin Pathol 85:278, 1986
44. Trumper LH, Brady G, Vicini S, Cossman J, Mak TW: Gene expression in single Reed Sternberg cells of Hodgkin's disease: Results from PCR generated single cell cDNA libraries. Ann Oncol 4:25, 1992
45. Trumper LH, Brady G, Bagg A, Gray D, Loke SL, Griesser H, Wagman R, Braziel R, Gascoyne RD, Vicini S, Iscove NN, Cossman J, Mak TW: Single-cell analysis of Hodgkin and Reed-Sternberg cells: Molecular heterogeneity of gene expression and p53 mutations. Blood 81:3097, 1993
46. Stein H, Mason D, Gerdes J, O'Connor N, Wainscoat J, Pallesen G, Gatter K, Falini B, Delsol G, Lemke H, Schwarting R, Lennert K: The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed-sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66:848, 1985
47. Andreesen R, Osterholz J, Lohr G, Bross K: A Hodgkin cell-specific antigen is expressed on a subset of auto- and alloactivated T (helper) lymphoblasts. Blood 63:1299, 1984
48. Kadin M: Histogenesis of Hodgkin's disease: Possible insights from a comparison with lymphomatoid papulosis. Hum Pathol 118:1085, 1987
49. Davis TH, Morton CC, Miller-Cassman R, Balk SP, Kadin ME: Hodgkin's disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone. N Engl J Med 326:1115, 1992
50. Kadin M, Sako D, Berliner N, Franklin W, Woda B, Borowitz M, Ireland K, Schweid A, Herzog P, Lange B, Dorfman R: Childhood Ki-1 lymphoma presenting with skin lesions and peripheral adenopathy. Blood 68:848, 1986
51. Kadin M: Ki-1 positive anaplastic large cell lymphoma: A clinicopathological entity? J Clin Oncol 9:533, 1991
52. Greer J, Kinney M, Collins R, Salhany K, Wolff S, Hainsworth J, Flexner J, Stein R: Clinical features of 31 patients with Ki-1 anaplastic large cell lymphoma. J Clin Oncol 9:539, 1991
53. Schwarting R, Gerdes J, Durkop H, Falini B, Pileri S, Stein H: Ber-H2: A new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope. Blood 74:1678, 1989
54. Engert A, Burrows F, Jung W, Tazzari P, Stein H, Pfreundschuh N, Diehl V, Thorpe P: Evaluation of ricin A chain-containing imunotoxins directed against the CD30 antigen as potential reagents for the treatment of Hodgkin's disease. Cancer Res 50:84, 1990
55. Andreesen R, Brugger W, Lohr G, Bross K: Human macrophages can express the Hodgkin's cell associated antigen Ki-1 (CD30). Am J Pathol 134:187, 1989
56. Cause A, Pohl C, Tschiersch A, Da Costa L, Jung W, Diehl V, Hasenclever D: Clinical significance of soluble CD30 antigen in the sera of patients with untreated Hodgkin's disease. Blood 77:1983, 1991
57. Falini B, Bolognesi A, Fleghini L, Tazzari P, Broe M, Stein H, Durkop H, Aversa F, Corneli P, Pizzolo G, Barbabietola G, Sabattini E, Pileri S, Martelli M, Stirpe F: Response of refractory Hodgkin's disease to monoclonal anti-CD30 immunotoxin. Lancet 339:1195, 1992
58. Falini B, Flenghi L, Fedeli L, Broe MK, Bonino C, Stein H, Durkop H, Bigerna B, Barbabietola G, Venturi S, Aversa F, Pizzolo G, Bartoli A, Pileri S, Sabatini E: In vivo targeting of Hodgkin and Reed-Sternberg cells of Hodgkin's disease with monoclonal antibody Ber-H2 (CD30): Immunohistological evidence. Br J Haematol 82:38, 1992
59. Winkler U, Gottstein C, Schon G, Kapp U, Wolf J, Hansmann ML, Bohlen H, Thorpe P, Diehl V, Engert A: Successful treatment of disseminated human Hodgkins disease in SCID mice with deglycosylated ricin a-chain immunotoxins. Blood 83:466, 1994
60. Kapp U, Wolf J, Hummel M, Pawlita M, Vonkalle C, Dallenbach F, Schwonzen M, Krueger G, Mullerlantzsch N, Fonatsch C, Stein H, Diehl V: Hodgkins lymphoma-derived tissue serially transplanted into severe combined immunodeficient mice. Blood 82:1247, 1993
61. Durkop H, Latza U, Hummel M, Eitelbach F, Seed B, Stein H: Molecular cloning and expression of a new member of the nerve growth receptor family that is characteristic for Hodgkin's disease. Cell 68:421, 1992
62. Ellis TM, Simms PE, Slivnick DJ, Jack HM, Fisher RI: Cd30 is a signal-transducing molecule that defines a subset of human activated cd45ro+ T-cells. J Immunol 151:2380, 1993
63. Gerdes J, Van Baarlen J, Pileri S, Schwarting R, Van Unnik J, Stein H: Tumor cell growth fraction in Hodgkin's disease. Am J Pathol 129:390, 1987
64. Strauchen J: Leukocyte common antigen in the differential diagnosis of Hodgkin's disease. Hematol Oncol 7:149, 1989
65. Werner M, Georgii A, Bernhards J, Hubner K, Schwarze E, Fischer R: Characterization of giant cells in Hodgkin's lymphoma by immunohistochemistry applied to randomly collected biopsies from the German Hodgkin Trial. Hematol Oncol 8:241, 1990
66. Nozawa Y, Wachi E, Tominaga K, Abe M, Wakasa H: A novel monoclonal antibody (FUN-1) identifies an activation antigen in cells of the B-cell lineage and Reed-Sternberg cells. J Pathol 169:309, 1993
67. Peckham M, Cooper E: Proliferation characteristics of the various classes of cells in Hodgkin's disease. Cancer 24:135, 1969
68. Kadin M, Astbury A: Long-term cultures of Hodgkin's tissue. A morphologic and radio-autographic study. Lab Invest 28:181, 1973
69. Schmid C, Sweeney E, Isaacson PG: Proliferating cell nuclear antigen (PCNA) expression in Hodgkin's disease. J Pathol 168:1, 1992
70. Hell K, Lorenzen J, Hansmann ML, Fellbaum C, Busch R, Fischer R: Expression of the proliferating cell nuclear antigen in the different types of hodgkins disease. Am J Clin Pathol 99:598, 1993
71. Sabattini E, Gerdes J, Gherlinzoni F, Poggi S, Zucchini L, Melilli G, Grigioni F, Delvecchio MT, Leoncini L, Falini B, Pileri SA: Comparison between the monoclonal antibodies Ki-67 and pc 10 in 125 malignant lymphomas. J Pathol 169:397, 1993
72. Drexler H, Gignac S, Hoffbrand A, Minowada J: Formation of multinuccleated cells in a Hodgkin's-disease-derived cell line. Int J Cancer 43:1083, 1989
73. Angel CA, Cullen RA, Pringle JH, Lauder I: Vimentin expression by Reed-Sternberg cells in Hodgkin's disease. Virchows Arch A Pathol Anat Histopathol 421:9, 1992
74. Carbone A, Gloghini A, Zanette I, Canal B, Rizzo A, Volpe R: Co-expression of Epstein-Barr virus latent membrane protein and vimentin in "aggressive" histological subtypes of Hodgkin's disease. Virchows Arch A Pathol Anat Histopathol 422:39, 1993
75. Bilbe G, Delabie J, Bruggen J, Richener H, Asselbergs FA, Cerletti N, Sorg C, Odink K, Tarcsay L, Wiesendanger W, DeWolf-Peeters C, Shipman R: Restin: A novel intermediate filament-associated protein highly expressed in the Reed-Sternberg cells of Hodgkin's disease. EMBO J 11:2103, 1992
76. Delabie J, Shipman R, Bruggen J, De Strooper B, van Leuven F, Tarcsay L, Cerletti N, Odink K, Diehl V, Bilbe G, De Wof-Peeters C: Expression of the novel intermediate filament-associated protein restin in Hodgkin's disease and anaplastic large-cell lymphoma. Blood 80:2891, 1992
77. Hilliker C, Delabie J, Speleman F, Bilbe G, Bruggen J, Vanleuven F, Vandenberghe H: Localization of the gene (rsn) coding for restin, a marker for Reed-Sternberg cells in hodgkins disease, to human chromosome band 12q24.3 and YAC cloning of the locus. Cytogenet Cell Genet 65:172, 1994
78. Nowell P, Hungerford D: A minute human chromosome in human chronic granulocytic leukemia. Science 132:1497, 1960
79. Spriggs A, Boddington M: Chromosomes of Sternberg-Reed cells. Lancet 2:153, 1962
80. Rowley J: Chromosomes in Hodgkin's disease. Cancer Treat Rep 66:639, 1982
81. Teerenhovi L, Lindholm C, Pakkala A, Franssila K, Stein H, Knuutila S: Unique display of a pathologic karyotype in Hodgkin's disease by Reed-Sternberg cells. Cancer Genet Cytogenet 34:305, 1988
82. Reeves B, Pickup V: The chromosome changes in non-Burkitt's lymphomas. Hum Genet 53:349, 1980
83. Cabanillas F, Pathak S, Trujillo J, Grant G, Cork A, Hagemeister F, Velasquez W, McLaughlin P, Redman J, Katz R, Butler J, Freireich E: Cytogenetic features of Hodgkin's disease suggest a possible origin from a lymphocyte. Blood 71:1615, 1988
84. Scheuten H, Sanger W, Duggan M, Weisenberger D, Mac-Lennan K, Armitage J: Chromosomal abnormalities in Hodgkin's disease. Blood 73:2149, 1989
85. Tilly H, Bastard C, Delastre T, Duval C, Bizet M, Lenormand B, Dauce J-P, Monconduit M, Piguet H: Cytogenetic studies in untreated Hodgkin's disease. Blood 77:1298, 1991
86. Cabanillas F: A review and interpretation of Cytogenetic abnormalities identified in Hodgkin's disease. Hematol Oncol 6:271, 1988
87. Poppema S, Kaleta J, Hepperle B: Chromosomal abnormalities in patients with Hodgkin's disease: Evidence for frequent involvement of the 14q chromosomal region but infrequent bcl-2 gene rearrangement in Reed-Sternberg cells. J Natl Cancer Inst 84:1789, 1992
88. Lorenzen J, Hansmann ML, Pezzella F, Hesse C, Kneba M, Gatter KC, Fischer R: Expression of the bcl-2 oncogene product and chromosomal translocation t(14; 18) in Hodgkin's disease. Hum Pathol 23:1205, 1992
89. Tonegawa S: Somatic generation of antibody diversity. Nature 302:57, 1983
90. Minden M, Mak T: The structure of the T-cell antigen receptor genes in normal and malignant T cells. Blood 68:327, 1986
91. Rabbitts T, Stinson A, Forster A, Eoroni L, Luzzato L, Catovsky D, Hammarstrom L, Smith C, Jones D, Karpas A, Minowada J, Taylor A: Heterogeneity of T-cell B-chain gene rearrangements in human leukemias and lymphomas. EMBO J 4:2217, 1985
92. Weiss L, Warnke R, Sklar J: Clonal antigen receptor gene rearrangements and Epstein-Barr viral DNA in tissues of Hodgkin's disease. Hematol Oncol 6:233, 1988
93. O'Connor N, Crick J, Gatter K, Mason D, Falini B, Stein H: Cell lineage in Hodgkin's disease. Lancet 1:158, 1987
94. Griesser H, Feller A, Lennert K, Minden M, Mak T: Clonal rearrangements of T-cell receptor and immunoglobulin antigen expression in different subclasses of Hodgkin's disease. Int J Cancer 40:157, 1987
95. Raghavachar A, Blinder T, Bartram C: Immunoglobulin and T-cell receptor gene rearrangements in Hodgkin's disease. Cancer Res 48:3591, 1988
96. Griesser H, Mak T: Immunogenotyping in Hodgkin's disease. Hematol Oncol 6:239, 1988
97. Griesser H, Feller A, Lennert K, Minden M, Mak T: Rearrangement of the B chain of the T cell antigen receptor and immunoglobulin genes in lymphoproliferative disorders. J Clin Invest 78:1179, 1986
98. Knowles DMI, Neri A, Pelicii PG, Burke JS, Wu A, Winberg CD, Sheibani K, Dalla-Favera R: Immunoglobulin and T-cell receptor B-chain rearrangement analysis of Hodgkin's disease: Implications for lineage determination and differential diagnosis. Proc Natl Acad Sci USA 83:7942, 1986
99. Roth MS, Schnitzer B, Bingham EL, Harnden CE, Hyder DM, Ginsburg D: Rearrangement of immunoglobulin and T-cell receptor genes in Hodgkin's disease. Am J Clin Pathol 131:331, 1988
100. Sundeen J, Lipford E, Uppenkamp M, Sussman E, Wahl L, Raffeld M, Cossman J: Rearranged antigen receptor genes in Hodgkin's disease. Blood 70:96, 1987
101. Cossman J, Sundeen J, Uppenkamp M, Sussman E, Wahl L, Coupland R, Lipford E, Raffeld M: Rearranging antigen-receptor genes in enriched Reed-Sternberg cell fractions of Hodgkin's disease. Hematol Oncol 6:205, 1988
102. Fenoglio-Prieser CM, Willman CL: Molecular biology and the pathologist. General principles and applications. Arch Pathol Lab Med 3:601, 1987
103. Knecht H, Joske DJ, Emery GA, Bachmann E, Bachmann F, Odermatt BF: Expression of human recombination activating genes (RAG-1 and RAG-2) in Hodgkin's disease. Blood 80:2867, 1992
104. Stetler-Stevenson M, Crush-Stanton S, Cossman J: Involvement of the bcl-2 gene in Hodgkin's disease. J Natl Cancer Inst 82:855, 1990
105. Gupta RK, Whelan JS, Lister TA, Young BD, Bodmer JG: Direct sequence analysis of the t(14; 18) chromosomal translocation in Hodgkin's disease. Blood 79:2084, 1992
106. Reid AH, Cunningham RE, Frizzera G, O'Leary TJ: bcl-2 rearrangement in Hodgkin's disease. Results of polymerase chain reaction, flow cytometry, and sequencing on formalin-fixed, paraffinembedded tissue. Am J Pathol 142:395, 1993
107. Lebrun DP, Ngan BY, Weiss LM, Huie P, Warnke RA, Cleary ML: The bcl-2 oncogene in Hodgkin's disease arising in the setting of follicular non-Hodgkins lymphoma. Blood 83:223, 1994
108. Shibata D, Hu E, Weiss LM, Brynes RK, Nathwani BN: Detection of specific t(14; 18) chromosomal translocations in fixed tissues. Hum Pathol 21:199, 1990
109. H gene rearrangement in lymphocyte predominance Hodgkin's disease: Results of Southern blot analysis and polymerase chain reaction. Am J Pathol 138:261, 1991
110. Louie DC, Kant JA, Brooks JJ, Reed JC: Absence of t(14; 18) major and minor breakpoints and of bcl-2 protein overproduction in Reed-Sternberg cells of Hodgkin's disease. Am J Pathol 139:1231, 1991
111. Athan E, Chadburn A, Knowles DM: The bcl-2 gene translocation is undetectable in Hodgkin's disease by Southern blot hybridization and polymerase chain reaction. Am J Pathol 141:193, 1992
112. Mitani S, Sugawara I, Shiku H, Mori S: Expression of c-myc oncogene product and ras family oncogene products in various human malignant lymphomas defined by immunohistochemical techniques. Cancer 62:2085, 1988
113. Sklar M, Kitchingman G: Isolation of activated ras transforming genes from two patients with Hodgkin's disease. Int J Radiat Oncol Biol Phys 11:49, 1985
114. Steenvorden A, Janssen J, Drexler H, Lyons J, Tesch H, Binder T, Jones D, Bartram C: Ras mutations in Hodgkin's disease. Leukemia 2:325, 1988
115. Jucker M, Schaadt M, Diehl V, Poppema S, Jones D, Tesch H: Heterogeneous expression of proto-oncogenes in Hodgkin's disease derived cell lines. Hematol Oncol 8:191, 1990
116. Gupta RK, Norton AJ, Thompson IW, Lister TA, Bodmer JG: p53 expression in Reed-Sternberg cells of Hodgkin's disease. Br J Cancer 66:649, 1992
117. Doussis IA, Pezzella F, Lane DP, Gatter KC, Phil D, Mason DY: An immunocytochemical study of p53 and bcl-2 protein expression in Hodgkin's disease. Am J Clin Pathol 99:663, 1993
118. Gupta RK, Patel K, Bodmer WF, Bodmer JG: Mutation of p53 in primary biopsy material and cell lines from Hodgkin disease. Proc Natl Acad Sci USA 90:2817, 1993
119. Cesarman E, Inghirami G, Chadburn A, Knowles DM: High levels of p53 protein expression do not correlate with p53 gene mutations in anaplastic large cell lymphoma. Am J Pathol 143:845, 1993
120. Sitar G, Brusamolino E, Bernasconi C, Ascari E: Isolation of Reed-Sternberg cells from lymph nodes of Hodgkin's disease patients. Blood 73:222, 1989
121. Pretlow T, Luberoff D, Hamilton L, Weinberger P, Maddox W, Durant J: Pathogenesis of Hodgkin's disease: Separation and culture of different kinds of cells from Hodgkin's disease in a sterile isokinetic gradient of Ficoll in tissue culture medium. Cancer 31:1120, 1973
122. Wilson J, Zaremba J, Pretlow T: Functional characterization of cells separated from suspensions of Hodgkin's disease tumor cells in an isokinetic gradient. Blood 50:783, 1977
123. McGuire R, Pretlow T II, Waering T, Bradley JEL: Hodgkin's cells and attached lymphocytes. A possible prognostic indicator in splenic tumor. Cancer 44:183, 1979
124. Sitar G, Brusamolino E, Scivetti P, Borroni R: The disaggregation of Hodgkin's lymph node: A preparative technique using a new dissociation chamber. Haematologica 72:23, 1987
125. Schaadt N, Diehl V, Stein H, Fonatsch C, Kirchner H: Two neoplastic cell lines with unique features derived from Hodgkin's disease. Int J Cancer 26:723, 1980
126. Diehl V, Kirchner H, Burrichte RH, Stein H, Fonatsch C, Gerdes J, Schaadt M, Heit W, Uchanska-Ziegler B, Ziegler A, Heintz F, Sueno K: Characteristics of Hodgkin's disease-derived cell lines. Cancer Treat Rep 66:615, 1982
127. Poppema S, De Jong B, Atmosoerodjo J, Idenburg V, Visser L, De Ley L: Morphologic, immunologic, enzyme, histochemical, and chromosomal analysis of a cell line derived from Hodgkin's disease. Cancer 55:683, 1985
128. Jones D, Scott C, Wright D, Stein H, Beverly P, Payne S, Crawford D: Phenotypic analysis of an established cell line derived from a patient with Hodgkin's disease. Hematol Oncol 3:133, 1985
129. Kamesaki H, Fukuhara S, Tatsumi E, Uchino H, Yamabe H, Shirakawa S, Hatanaka N, Honjo T: Cytochemical, immunologic, chromosomal and molecular genetic analysis of a novel cell line derived from Hodgkin's disease. Blood 68:285, 1986
130. Drexler H, Gaedicke G, Lok M, Diehl V, Minowada J: Hodgkin's disease derived cell lines HDLM-2 and L-428: Comparison of morphology, immunological and isoenzyme profiles. Leuk Res 10:487, 1986
131. Poppema S, Visser L, De Jong B, Brinker M, Atmosoerodjo J, Timens W: The typical Reed-Sternberg phenotype and Ig gene rearrangement of Hodgkin's disease derived cell line ZO indicates a B-cell origin. Recent Results Cancer Res 117:67, 1989
132. Jones D, Furley A, Gerdes J, Greaves M, Stein H, Wright D: Phenotypic and genotypic analysis of two cell lines derived from Hodgkin's disease tissue biopsies. Recent Results Cancer Res 117:62, 1989
133. Naumovski L, Utz P, Bergstrom S, Morgan R, Molina A, Toole J, Glader B, McFall P, Weiss L, Warnke R, Smith S: SUPHD1: A new Hodgkin's disease-derived cell line with lymphoid features produces interferon-γ. Blood 74:2733, 1989
134. Drexler H, Leber B, Norton J, Yaxley J, Tatsumi E, Hoffbrand A, Minowada J: Genotypes and immunophenotypes of Hodgkin's disease-derived cell lines. Leukemia 2:371, 1988
135. Athan E, Paietta E, Papenhausen P, Augenlicht L, Wiernik P, Gallagher R: Stability of multiple antigen receptor gene rearrangements and immunophenotype in Hodgkin's disease-derived cell line L428 and variant subline L428KSA. Leukemia 3:505, 1989
136. Falk M, Tesch H, Stein H, Diehl V, Jones D, Fonatsch C, Bornkamm G: Phenotype versus immunoglobulin and T-cell receptor genotype of Hodgkin-derived cell lines: Activation of immature lymphoid cells in Hodgkin's disease. Int J Cancer 40:262, 1987
137. Hellman S, Jaffe E, DeVita JVT: Hodgkin's disease, in De-Vita JVT, Hellman S, Rosenberg S (eds): Cancer: Principles and Practice of Oncology. Philadelphia, Lippincott, 1989, chapter 49, p 1696
138. Waddell C, Cimo P: Idiopathic thrombocytopenic purpura occurring in Hodgkin's disease after splenectomy: A report of two cases and review of the literature. Am J Hematol 7:381, 1979
139. Mizel S: Interleukin 1 and T cell activation, Immunol Rev 63:51, 1982
140. Falkoff R, Maraguchi A, Hong J-X, Butler J, Dinarello C, Fauci A: The effects of interleukin 1 on human B cell activation and proliferation. J Immunol 131:801, 1983
141. Schmidt J, Mizel S, Cohen D, Green I: Interleukin 1, a potential regulator of fibroblast proliferation. J Immunol 128:2177, 1982
142. Murphy P, Simon P, Willoughby W: Endogenous pyrogens made by rabbit peritoneal exudate cells are identical with lymphocyte activation factors made by rabbit alveolar macrophages. J Immunol 124:2498, 1980
143. Hsu S-M, Zhao X: Expression of interleukin-1 in Reed-Sternberg cells and neoplastic cells from true histiocytic malignancies. Am J Pathol 125:221, 1986
144. Ford R, Mehta S, Davis F, Maizel A: Growth factors in Hodgkin's disease. Cancer Treat Rep 66:633, 1982
145. Hsu S-M, Krupen K, Lachman L: Heterogeneity of interleukin 1 production in cultured Reed-Sternberg cell lines HDLM-1, HDLM-1d, and KM-H2. Am J Pathol 135:33, 1989
146. Grass H-J, Brach M, Drexler H-G, Bonifer R, Mertelsmann R, Herrmann F: Expression of cytokine genes, cytokine receptor genes, and transcription factors in cultured Hodgkin and Reed-Sternberg cells. Cancer Res 52:3353, 1992
147. Xerri L, Birg F, Guigou V, Bouabdallah R, Poizot MI, Hassoun J: In situ expression of the IL-1-alpha and TNF-alpha genes by Reed-Sternberg cells in Hodgkin's disease. Int J Cancer 50:689, 1992
148. Matsushuma K, Procopio A, Abe H, Scala G, Ortaldo J, Oppenheim J: Production of interleukin 1 activity by normal human peripheral B lymphocytes. J Immunol 135:1132, 1985
149. Ree H, Crowley J, Dinarello C: Anti-interleukin-1 reactive cells in Hodgkin's disease. Cancer 59:1717, 1987
150. Leonard W, Depper J, Crabtree G, Rudikoff S, Pumphrey J, Robb R, Kronke M, Svetlik P, Peffer N, Waldmann T, Greene W: Molecular cloning and expression of cDNAs for the human interleukin-2 receptor. Nature 311:626, 1984
151. Robb R, Rusk C, Yodoi J, Greene W: Interleukin 2 binding molecule distinct from the tac protein: Analysis of its role in formation of high affinity receptors. Proc Natl Acad Sci USA 84:2002, 1987
152. Pizzolo G, Chilosi M, Semenzato G, Caligaris-Cappio F, Fiore-Donati L, Peron G, Janossy G: Immunohistological analysis of Tac antigen expression in tissues involved by Hodgkin's disease. Br J Cancer 50:415, 1984
153. Strauchen J, Breakstone B: IL-2 receptor expression in human lymphoid lesions: Immunohistochemical study of 166 cases. Am J Pathol 126:506, 1987
154. Sheibani K, Winberg C, Van de Velde S, Blayney D: Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas: An immunohistologic study of 300 cases. Am J Pathol 127:27, 1987
155. Tesch H, Gunther A, Abts H, Jucker M, Klein S, Krueger GR, Diehl V: Expression of interleukin-2R alpha and interleukin-2R beta in Hodgkin's disease. Am J Pathol 142:1714, 1993
156. Tesch H, Herrmann T, Abts H, Diamantstein T, Diehl V: High affinity IL-2 receptors on a Hodgkin's derived cell line. Leuk Res 14:953, 1990
157. Pizzolo G, Chilosi M, Semanzato G: The soluble interleukin-2 receptor in haematological disorders. Br J Haematol 67:377, 1987
158. Pizzolo G, Chilosi M, Vinante F, Pazzo F, Lestani M, Perona G, Benedetti F, Todeschini G, Vincenzi C, Trentin L, Semenzato G: Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease. Br J Cancer 55:427, 1987
159. Pui C-H, Ip S, Thompson E, Williams J, Brown M, Dodge R, De Hoyos R, Berard C, Crist W: High serum interleukin-2 receptor levels correlate with a poor prognosis in children with Hodgkin's disease. Leukemia 3:481, 1989
160. Merz H, Fliedner A, Orscheschek K, Binder T, Sebald W, Muller-Hermelink H, Feller A: Cytokine expression in T-cell lymphomas and Hodgkin's disease. Am J Pathol 139:1173, 1991
161. Paul W, Ohara J: B-cell stimulatory factor-1/interleukin-4. Annu Rev Immunol 5:429, 1987
162. Newcom S, Ansari A, Gu L: Interleukin-4 is an autocrine growth factor secreted by the L-428 Reed-Sternberg cell. Blood 79:191, 1992
163. Sanderson C, Campbell H, Young I: Molecular and cellular biology of eosinophil differentiation factor (interleukin-5) and its effects on human and mouse B cells. Immunol Rev 102:29, 1988
164. Clutterbuck E, Hirst E, Sanderson C: Human interleukin-5 regulates the production of eosinophils in human bone marrow cultures. Blood 73:1504, 1989
165. Samoszuk M, Nansen L: Detection of interleukin-5 messenger RNA in Reed-Sternberg cells of Hodgkin's disease with eosinophilia. Blood 75:13, 1990
166. Kishimoto T: The biology of interleukin-6. Blood 74:1, 1989
167. Jucker M, Abts H, Ki W, Schindler R, Merz H, Gunther A, Von Kalle C, Schaadt M, Diamantstein T, Feller A, Krueger G, Diehl V, Blankenstein T, Tesch H: Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease. Blood 77:2413, 1991
168. Foss HD, Herbst H, Oelmann E, Samol J, Grebe M, Blankenstein T, Matthes J, Qin ZH, Falini B, Pileri S, Diamantstein T, Stein H: Lymphotoxin, tumour necrosis factor and interleukin-6 gene transcripts are present in Hodgkin and Reed-Sternberg cells of most Hodgkin's disease cases. Br J Haematol 84:627, 1993
169. Merz H, Houssiau F, Orscheschek K, Renauld J, Fliedner A, Herin M, Noel H, Kadin M, Mueller-Hermelink H, Van Snick J, Feller A: Interleukin-9 expression in human malignant lymphomas: Unique association with Hodgkin's disease and large cell anaplastic lymphoma. Blood 78:1311, 1991
170. Gruss H-J, Brach M, Drexler H-G, Bross K, Herrmann F: Interleukin 9 is expressed by primary and cultured Hodgkin and Reed-Sternberg cells. Cancer Res 52:1026, 1992
171. Schmitt E, Van Brandwijk R, Van Snick J, Siebold B, Rude E: TCGF III/P40 is produced by naive murine CD4+ T cells but is not a general T cell growth factor. Eur J Immunol 19:2167, 1989
172. Cottenhove C, Simpson R, Van Snick J: Functional and structural characterization of p40 a mouse glycoprotein with T-cell growth factor activity. Proc Natl Acad Sci USA 85:8934, 1988
173. Katay I, Wirnitzer U, Burrichter H, Von Kalle C, SchellFrederick E, Diehl V, Schaadt M: L428 cells derived from Hodgkin's disease produce E-rosette-inhibiting factor. Blood 76:791, 1990
174. Paietta E, Racevskis J, Stanley E, Andreef M, Papenhausen P, Wiernik P: Expression of the macrophage growth factor, CSF-1 and its receptor c-fms by a Hodgkin's disease-derived cell line and its variants. Cancer Res 50:2049, 1990
175. Byrne P, Heit W, March C: Human granulocyte-macrophage colony-stimulating factor purified from a Hodgkin's tumor cell line. Biochim Biophys Acta 874:266, 1986
176. Newcom S, Muth L, Parker E: Production of monoclonal antibodies that detect Hodgkin's high molecular weight transforming growth factor-B. Blood 75:2434, 1990
177. Hsu SM, Lin J, Xie SS, Hsu PL, Rich S: Abundant expression of transforming growth factor-beta 1 and -beta 2 by Hodgkin's Reed-Sternberg cells and by reactive T lymphocytes in Hodgkin's disease. Hum Pathol 24:249, 1993
178. Kadin M, Agnarrson B, Ellingsworth L, Newcom SR: Immunohistochemical evidence of a role for transforming growth factor beta in the pathogenesis of nodular sclerosing Hodgkin's disease. Am J Pathol 136:1209, 1990
179. Ruco L, Pomponi D, Pigott R, Stoppacciaro A, Monardo F, Uccini S, Boraschi D, Tagliabue A, Santoni A, Dejana E, Mantovani A, Baroni CD: Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. Am J Pathol 137:1163, 1990
180. Kretschmer C, Jones D, Morrison K, Schluter C, Feist W, Ulmer AJ, Arnold J, Matthes J, Diamantstein T, Flad H-D, Gerdes J: Tumor necrosis factor alpha and lymphotoxin production in Hodgkin's disease. Am J Pathol 137:341, 1990
181. Sappino A, Seelentag W, Pelte M, Alberto P, Vassalli P: Tumor necrosis factor/cachectin and lymphotoxin gene expression in lymph nodes from lymphoma
182. MacMahon B: Epidemiology of Hodgkin's disease. Cancer Res 26:1189, 1966
183. Gutensohn N, Cole P: Epidemiology of Hodgkin's disease. Semin Oncol 7:92, 1980
184. Gutensohn N, Cole P: Childhood social environment and Hodgkin's disease. N Engl J Med 304:155, 1981
185. Evans A, Gutensohn N: A population-based case-control study of EBV and other viral antibodies among persons with Hodgkin's disease and their siblings. Int J Cancer 34:149, 1984
186. Gledhill S, Gallagher A, Jones D, Krajewski A, Alexander F, Klee E, Wright D, O'Brien C, Onions D, Jarrett R: Viral involvement in Hodgkin's disease: Detection of clonal type A Epstein-Barr virus genomes in tumour samples. Br J Cancer 64:227, 1991
187. Torelli G, Marasca R, Luppi M, Selleri L, Ferrari S, Narni F, Mariano M, Federico M, Ceccherini-Nelli L, Bendinelli G, Montorsi M, Artusi T: Human herpesvirus-6 in human lymphomas: Identification of specific sequences in Hodgkin's lymphomas by polymerase chain reaction. Blood 77:2251, 1991
188. Miller R, Beebe G: Infectious mononucleosis and the empirical risk of cancer. J Nat Cancer Inst 50:315, 1973
189. Connelly R, Christine B: A cohort study of cancer following infectious mononucleosis. Cancer Res 34:1172, 1974
190. Rosdahl N, Larsen S, Clemmensen J: Hodgkin's disease in patients with infectious mononucleosis: 30 years' experience. Br Med J 2:253, 1974
191. Carter C, Brown T, Herbert J, Heath C: Cancer incidence following infectious mononucleosis. Am J Epidemiol 105:30, 1977
192. Munoz N, Davidson R, Witthoff B, Ericsson J, De The G: Infectious mononucleosis and Hodgkin's disease. Int J Cancer 22:10, 1978
193. Kvaale G, Hoiby E, Pederson E: Hodgkin's disease in patients with previous infectious mononucleosis. Int J Cancer 23:593, 1979
194. Johansson B, Klein G, Henle W, Henle G: Epstein-Barr virus (EBV) associated antibody patterns in malignant lymphoma and leukemia. I. Hodgkin's disease. Int J Cancer 6:450, 1970
195. Levine P, Ablashi D, Berard C, Carbone P, Waggoner D, Malam L: Elevated antibody titers to Epstein-Barr virus in Hodgkin's disease. Cancer 27:416, 1971
196. DeSchryver A, Klein G, Henle G, Henle W, Cameron H, Santesson L, Clifford P: EB-virus associated serology in malignant disease: Antibody levels to viral capsid antigens (VCA), membrane antigens (MA), and early antigens (EA) in patients with various neoplastic conditions. Int J Cancer 9:353, 1972
197. Mueller N, Evans A, Harris N, Comstock G, Jellum E, Magnus K, Orentreich N, Folk B, Vogelman J: Hodgkin's disease and Epstein-Barr virus: Altered antibody patterns before diagnosis. N Engl J Med 320:689, 1989
198. Poppema S, van Imhoff G, Torensma R, Smit J: Lymphadenopathy morphologically consistent with Hodgkin's disease associated with Epstein-Barr virus infection. Am J Clin Pathol 84:385, 1985
199. Pallesen G, Hamilton-Dutoit S, Rowe M, Youn L: Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 1:337, 1991
200. Herbst H, Dallenbach F, Hummel M, Niedobitek G, Pileri S, Muller-Lantzsch N, Stein H: Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc Natl Acad Sci USA 88:4766, 1991
201. Pallesen G, Sandvej K, Hamilton-Dutoit S, Rowe M, Young L: Activation of Epstein-Barr virus replication in Hodgkin and Reed-Sternberg cells. Blood 78:1162, 1991
202. Herbst H, Steinbrecher E, Niedobitek G, Young L, Brooks L, Muller-Lantzsch N, Stein H: Distribution and phenotype of Epstein-Barr virus-harboring cells in Hodgkin's disease. Blood 80:484, 1992
203. Weiss L, Strickler J, Warnke R, Purtillo D, Sklar J: Epstein-Barr viral DNA in tissues of Hodgkin's disease. Am J Pathol 129:86, 1987
204. Weiss L, Movahed L, Warnke R, Sklar J: Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med 320:502, 1989
205. Anagnostopoulos I, Herbst H, Niedobitek G, Stein H: Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1 positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization. Blood 74:810, 1989
206. Staal S, Ambinder R, Beschorner W, Hayward G, Mann R: A survey of Epstein-Barr virus DNA in lymphoid tissue. Am J Clin Pathol 91:1, 1989
207. Uccini S, Monardo F, Stoppacciaro A, Gradilone A, Agliano A, Faggioni A, Manzari V, Vago L, Costanzi G, Rugo L, Baroni C: High frequency of Epstein-Barr virus genome detection in Hodgkin's disease of HIV-positive patients. Int J Cancer 46:581, 1990
208. Bignon Y-J, Bernard D, Cure H, Fonck Y, Pauchard J, Travade P, Legros M, Dastugue B, Plagne R: Detection of Epstein-Barr viral genomes in lymph nodes of Hodgkin's disease patients. Mol Carcinog 3:9, 1990
209. Herbst H, Niedobitek G, Kneba M, Hummel M, Finn T, Anagnostopoulos I, Bergholz M, Krieger G, Stein H: High incidence of Epstein-Barr virus genomes in Hodgkin's disease. Am J Pathol 137:13, 1990
210. Knecht H, Odermatt B, Bachmann E, Texeira S, Sahli R, Hayoz D, Heitz P, Bachmann F: Frequent detection of Epstein-Barr virus DNA by the polymerase chain reaction in lymph node biopsies from patients with Hodgkin's disease without genomic evidence of B- of T-cell clonality. Blood 78:760, 1991
211. Brocksmith D, Angel C, Pringle J, Lauder I: Epstein-Barr viral DNA in Hodgkin's disease: Amplification and detection using polymerase chain reaction. J Pathol 165:11, 1991
212. Stein H, Herbst H, Anagnostopoulos I, Niedobitek G, Dallenbach F, Kratzsch H-C: The nature of Hodgkin and Reed-Sternberg cells, their association with EBV, and their relationship to anaplastic large cell lymphoma. Ann Oncol 2:33, 1991 (suppl 2)
213. Wright C, Reid A, Tsai M, Venter K, Murari P, Frizzera G, O'Leary T: Detection of Epstein-Barr virus sequences in Hodgkin's disease by the polymerase chain reaction. Am J Pathol 139:393, 1991
214. Weiss L, Chen Y, Liu X, Shibata D: Epstein-Barr virus and Hodgkin's disease. A correlative in situ hybridization and polymerase chain reaction study. Am J Pathol 139:1259, 1991
215. Brousset P, Chittal S, Schlaifer D, Icart J, Payen C, Rigal-Huguet F, Voigt J-J, Delsol G: Detection of Epstein-Barr virus messenger RNA in Reed-Stemberg cells of Hodgkin's disease by in situ hybridization with biotinylated probes on specially processed modified acetone methyl benzoate xylene (ModAMeX) sections. Blood 77:1781, 1991
216. Wu T-C, Mann R, Charache P, Hayward D, Staal S, Lambe B, Ambinder R: Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin's disease. Int J Cancer 46:801, 1990
217. Hennessy K, Fennewald S, Hummel M, Cole T, Kieff E: A membrane protein encoded by Epstein-Barr virus in latent growth transforming infection. Proc Natl Acad Sci USA 81:7207, 1984
218. Wang D, Liebowitz D, Kieff E: An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831, 1985
219. Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, Kieff E, Bickinson A: Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65:1107, 1991
220. Fincke J, Fritzen R, Ternes P, Trivedi P, Bross K, Lange W, Mertelsmann R, Dolken G: Expression of bcl-2 in Burkitt's lymphoma cell lines: Induction by latent Epstein-Barr virus genes. Blood 80:459, 1992
221. Bhagat SK, Medeiros LJ, Weiss LM, Wang J, Raffeld M, Stetler-Stevenson M: bcl-2 expression in Hodgkin's disease. Correlation with the t(14; 18) translocation and Epstein-Barr virus. Am J Clin Pathol 99:604, 1993
222. Khan G, Gupta RK, Coates PJ, Slavin G: Epstein-barr virus infection and bcl-2 proto-oncogene expression-Separate events in the pathogenesis of Hodgkin's disease. Am J Pathol 143:1270, 1993
223. Armstrong AA, Gallagher A, Krajewski AS, Jones DB, Wilkins BS, Onions DE, Jarrett RF: The expression of the EBV latent membrane protein (LMP-1) is independent of CD23 and bcl-2 in Reed-Sternberg cells in Hodgkin's disease. Histopathology 21:72, 1992
224. Jiwa NM, Kanavaros P, van der Valk P, Walboomers JM, Horstman A, Vos W, Mullink H, Meijer CJ: Expression of c-myc and bcl-2 oncogene products in Reed-Sternberg cells independent of presence of Epstein-Barr virus. J Clin Pathol 46:211, 1993
225. Raab-Traub N, Flynn K: The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47:883, 1986
226. Chang KL, Albujar PF, Chen YY, Johnson RM, Weiss LM: High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of Hodgkin's disease occurring in Peru. Blood 81:496, 1993
227. Fingeroth J, Weis J, Tedder T, Strominger J, Biro P, Fearon D: Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci USA 81:4510, 1984
228. Kikuta H, Taguchi Y, Tomizawa K, Kojima K, Kawamura N, Ishikaza A, Sakiyama Y, Matsumoto S, Imai S, Kinoshita T: Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature 333:455, 1988
229. Jones J, Shurim S, Abramowsky C, Tubbs R, Sciotto C, Wahl R, Sands J, Gottman D, Katz B, Sklar T: T cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N Engl J Med 318:733, 1988
230. Harabuchi Y, Yamanaka N, Kataura A, Imai S, Knoshita T, Mizuno F, Osato T: Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 335:128, 1990
231. Klein G: Viral latency and transformation: The strategy of Epstein-Barr virus. Cell 58:5, 1989
232. Klein G: The Epstein-Barr virus-carrying cells in Hodgkin's disease. Blood 80:299, 1992
233. Willemze R, Scheffer E, Van Vloten W, Meijer C: Lymphomatoid papulosis and Hodgkin's disease: Are they related? Arch Dermatol Res 275:159, 1983
234. Kadin M: Common activated helper-T cell origin for Jymphomatoid papulosis, mycosis fungoides, and some types of Hodgkin's disease. Lancet 2:864, 1985
235. Weiss L, Wood G, Trela M, Warnke R, Sklar J: Clonal T-cell populations in lymphomatoid papulosis: Evidence of a lympho-proliferative origin for a clinically benign disease. N Engl J Med 315:475, 1986
236. Kadin M, Vonderheid E, Sako D, Clayton L, Olbricht S: Clonal composition of T cells in lymphomatoid papulosis. Am J Pathol 126:13, 1987
237. Kadin M, Nasu K, Sako D, Said J, Vonderheid E: Lymphomatoid papulosis: A cutaneous proliferation of activated helper T cells expressing Hodgkin's disease-associated antigens. Am J Pathol 119:315, 1985
238. Slater D: Epstein-Barr virus: An aetiological factor in cutaneous lymphoproliferative disorders? J Pathol 165:1, 1991
239. Haluska F, Tsujimoto Y, Croce C: Oncogene activation by chromosome translocation in human malignancy. Annu Rev Genet 21:321, 1987
240. Klein G, Klein E: Evolution of tumors and the impact of molecular oncology. Nature 315:190, 1985
241. Whittle H, Brown J, Marsh K, Greenwood B, Seidelin P, Tighe H, Wedderburn L: T-cell control of Epstein-Barr virus-infected B cells is lost during P. falciparum malaria. Nature 312:449, 1984
242. Haluska F, Finver S, Tsujimoto Y, Croce C: The t(8; 14) chromosomal translocation occurring in B-cell malignancies results from mistakes in V-D-J joining. Nature 324:158, 1986
243. Robison L, Mertene A, Frizzera G: Lymphoproliferative disorders associated with immunodeficiency, in Magrath I (ed): The Non-Hodgkin's Lymphomas. London, UK, Edward Arnold, 1990, chapter 9, p 135
244. Ziegler J, Beckstead J, Volberding P, Abrams D, Levine A, Lukes R, Burkes R, Meyer P, Metrola C, Mouradian J, Moore A, Riggs S, Butler J, Cabanillas F, Hersh E, Newell G, Laubenstein L, Knowles D, Odajnyk C, Raphael B, Koziner B, Urmacher C, Clarkson B: Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med 311:565, 1984
245. Aisenberg AC, Wilkes BM, Jacobson JO: The bcl-2 gene is rearranged in many diffuse B-cell lymphomas. Blood 71:969, 1988
246. Gauwerky C, Haluska F, Tsujimoto Y, Nowell P, Croce C: Evolution of B-cell malignancy: Pre-B-cell leukemia resulting from MYC activation in a B-cell neoplasm with a rearranged BCL2 gene. Proc Natl Acad Sci USA 85:8548, 1988
247. Hessol N, Katz M, Kiu J, Buchbinder S, Rubino C, Holmberg S: Increased incidence of Hodgkin disease in homosexual men with HIV infection. Ann Intern Med 117:309, 1992
248. Garnier G, Michiels J: HIV associated Hodgkin disease. Ann Intern Med 115:233, 1991
249. Herndier BG, Sanchez HC, Chang KL, Chen YY, Weiss LM: High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of HIV-associated Hodgkin's disease. Am J Pathol 142:1073, 1993